News, Deals & Awards
Global law firm Ashurst has advised FSI SGR on the signing of a binding agreement with Sterling, a leading manufacturer of active principles used to treat pathologies for oncologic, respiratory and dermatologic disease, for the creation of a partnership aimed at creating a European leader in the active pharmaceutical ingredients.
Key Contacts
We bring together lawyers of the highest calibre with the technical knowledge, industry experience and regional know-how to provide the incisive advice our clients need.
Keep up to date
Sign up to receive the latest legal developments, insights and news from Ashurst. By signing up, you agree to receive commercial messages from us. You may unsubscribe at any time.
Sign up
